Avita Medical News and Activities
Presence
Avita Medical develops regenerative medicine solutions for skin repair. It offers cell-based treatment systems, wound care products, and related services for hospitals, burn centers, and clinicians.
Avita Medical products and services overview:
- Regenerative medicine
- Wound care
- Skin repair systems
- Cell therapy tools
- Burn treatment
Revenue: ~$64 million
Employees: 260
Headquarters: Valencia, United Kingdom (UK)
Avita Medical is one of the...
Avita Medical is a company listed under the stock ticker RCEL (GB).
Executives
View the org chart displaying its 25 main executives
Most searched biographies at Avita Medical
- Cary Vance, President and Chief Executive Officer
- Suzanne Crowe, Director
- Michael Tarnoff, Non-Executive Director
Popular executive movements at Avita Medical
- Cary Vance, who was Interim Chief Executive Officer and Chairman of the Board, is promoted to President and Chief Executive Officer (posted on May 4 2026).
- Jan Reed, who was Lead Independent Director, is promoted to Chairman of the Board (posted on May 4 2026).
- Joe Woody has joined the company as Non-Executive Director (posted on January 6 2026).
Click here to view some more movements at Avita Medical
Create your alert
to follow the executive moves at Avita Medical.
Biotechnology
Avita Medical has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
Popular contacts in Biotechnology
News
Press releases by Avita Medical
- AVITA Medical Reports Second Quarter Financial Results | AVITA Medical
- AVITA Medical to Announce Second Quarter 2023 Financial Results | AVITA Medical
- AVITA Medical Submits FDA PMA Supplement for RECELL GO | AVITA Medical
- AVITA Medical Rejoins the Russell 3000 Index | AVITA Medical
- AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients | AVITA Medical
- AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer | AVITA Medical
- AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects | AVITA Medical
- AVITA Medical to Host Investor Webinar Briefing | AVITA Medical
- AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance | AVITA Medical
- AVITA Medical to Announce First Quarter 2023 Financial Results | AVITA Medical
- View more press releases Close
Social media about Avita Medical
- Avita Medical on Wikipedia, Google News & Yahoo Finance
- Avita Medical on LinkedIn, X (Twitter) & YouTube
